Share this page:
Looking for your tests results? Looking for reference ranges?
Also known as: [May be referred to by brand name (see MedlinePlus Drug Information)]
Formal name: Levetiracetam

At a Glance

Why Get Tested?

To determine the concentration of levetiracetam in the blood to establish an individualized dose; to detect toxicity or verify that a person is taking the medication as prescribed (compliance); to monitor during health changes that may affect drug clearance and/or kidney function

When to Get Tested?

Initially when establishing dosage; when indicated to detect low or excessive (potentially toxic) concentrations; when a person has decreased kidney function; sometimes to verify compliance

Sample Required?

A blood sample drawn from a vein in your arm

Test Preparation Needed?


The Test Sample

What is being tested?

Levetiracetam is a drug that is used to treat certain seizure disorders (also called epilepsy). It is prescribed as an adjunctive (secondary) treatment in combination with other antiepileptic drugs. This test measures the amount of levetiracetam in the blood.

Epilepsy affects the brain's ability to transmit electrical impulses and to regulate nerve activity. During a seizure, a person may experience changes in consciousness, alterations in sight, smell, and taste, and may experience convulsions. The frequency of seizures varies from a single episode, to occasional seizures, to recurrent seizures. Seizures are categorized by the parts of the brain and body that are affected. Levetiracetam is prescribed to help prevent specific types of recurrent seizures.

Levetiracetam is one of several newer second-generation antiepileptic drugs. It has a wider therapeutic range than many existing first-generation seizure medications. That is, the range of concentration in the blood in which the drug is effective without being toxic is broader, making it somewhat safer. It is also associated with fewer severe side effects and does not interact with as many other drugs. Since it is relatively new, however, it has less of a use history – its long-term safety and efficacy and its appropriate therapeutic range are less well established.

Because levetiracetam has a wider therapeutic range, it does not need to be monitored in the same manner as first-generation antiepileptic drugs. (For further discussion of this, see the article on Therapeutic Drug Monitoring.) However, there are circumstances in which it is useful and sometimes necessary to measure blood levels. Some of these include:

  • To establish the range that is therapeutic for an individual; after treatment has started and the individual has relief from symptoms (no seizures) and suffers no side effects, the concentration of the drug in the blood is determined. The range around this value is considered therapeutic for the person and may be used to evaluate their treatment in the future if their health status or other factors change.
  • To verify that a person's symptoms (seizures or side effects) are not due to too little or too much drug; to verify that a person is taking the medication as prescribed
  • To evaluate and adjust the dose as necessary in certain conditions such as:
    • Kidney disease—levetiracetam is cleared from the body by the kidneys, so anything that affects kidney function can affect blood levels of the drug.
    • A change or addition of other drugs
    • Aging—people typically are prescribed seizure medications for life and, as they age, the amount of drug needed to be effective may change.
    • Pregnancy—this condition can temporarily affect drug metabolism and clearance.

At the start of therapy, doses of levetiracetam may be gradually increased until a standard amount is reached. Once a stable dose is achieved, a blood level may be measured to ensure that it is within the therapeutic range. Since levetiracetam is an adjunct (secondary) medication, the doctor will consider the effectiveness of both drugs that are prescribed and adjust them as necessary.

How is the sample collected for testing?

A blood sample is obtained by inserting a needle into a vein in the arm.

NOTE: If undergoing medical tests makes you or someone you care for anxious, embarrassed, or even difficult to manage, you might consider reading one or more of the following articles: Coping with Test Pain, Discomfort, and Anxiety, Tips on Blood Testing, Tips to Help Children through Their Medical Tests, and Tips to Help the Elderly through Their Medical Tests.

Another article, Follow That Sample, provides a glimpse at the collection and processing of a blood sample and throat culture.

Is any test preparation needed to ensure the quality of the sample?

No test preparation is needed.

The Test

Common Questions

Ask a Laboratory Scientist

This form enables you to ask specific questions about your tests. Your questions will be answered by a laboratory scientist as part of a voluntary service provided by one of our partners, American Society for Clinical Laboratory Science. If your questions are not related to your lab tests, please submit them via our Contact Us form. Thank you.

* indicates a required field

Please indicate whether you are a   

You must provide a valid email address in order to receive a response.

| Read The Disclaimer

Spam Prevention Equation

| |

Article Sources

« Return to Related Pages

NOTE: This article is based on research that utilizes the sources cited here as well as the collective experience of the Lab Tests Online Editorial Review Board. This article is periodically reviewed by the Editorial Board and may be updated as a result of the review. Any new sources cited will be added to the list and distinguished from the original sources used.

Cavazos, J. (Updated 2013 March 11). Epilepsy and Seizures. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/1184846-overview through http://emedicine.medscape.com. Accessed April 2013.

(© 1995-2013). Levetiracetam, Serum. Mayo Clinic Mayo Medical Laboratories [On-line information]. Available online at http://www.mayomedicallaboratories.com/test-catalog/Overview/83140 through http://www.mayomedicallaboratories.com. Accessed April 2013.

Ochoa, J. and Riche, W. (Updated 2012 October 25). Antiepileptic Drugs. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/1187334-overview through http://emedicine.medscape.com. Accessed April 2013.

Johnson-Davis, K. (Reviewed 2013 February). Seizure Disorders – Epilepsy. ARUP Consult [On-line information]. Available online at http://www.arupconsult.com/Topics/SeizureDis.html?client_ID=LTD#tabs=0 through http://www.arupconsult.com. Accessed April 2013.

(Revised 2009 September 1) Levetiracetam. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/druginfo/meds/a699059.html. Accessed April 2013.

Rosenow, F. (2012). Lamotrigine Compared With Levetiracetam in the Initial 26 Weeks of Monotherapy for Focal and Generalised Epilepsy. Medscape News from J Neurol Neurosurg Psychiatry. 2012;83(11):1093-1098. [On-line information]. Available online at http://www.medscape.com/viewarticle/772590 through http://www.medscape.com. Accessed April 2013.

Ha, H. and Bellanger, R. (2013). Epilepsy: Treatment and Management. Medscape Today News from US Pharmacist. 2013;38(1):35-39 [On-line information]. Available online at http://www.medscape.com/viewarticle/779381 through http://www.medscape.com. Accessed April 2013.

Buck, M. (2012). Recent Literature on Pediatric Antiepileptic Drugs. Medscape Today News from Pediatr Pharm. 2012;18(12) [On-line information]. Available online at http://www.medscape.com/viewarticle/781121 through http://www.medscape.com. Accessed April 2013.

Krasowski, M. (2010 May 11). Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications. Pharmaceuticals 2010, 3(6), 1909-1935. [On-line information]. Available online at http://www.mdpi.com/1424-8247/3/6/1909 through http://www.mdpi.com. Accessed April 2013.

Krishna, K. et. al. (2011 October). Levetiracetam. JAPI v 59 [On-line information]. PDF available for download at http://www.japi.org/october_2011/09_dr_levetiracetam.pdf through http://www.japi.org. Accessed April 2013.

(Revised 2013 February). LevETIRAcetam. Merck Manual for Healthcare Professionals [On-line information]. Available online at http://www.merckmanuals.com/professional/lexicomp/levetiracetam.html through http://www.merckmanuals.com. Accessed April 2013.

Buck, M. (2012 December 12). Recent Literature on Pediatric Antiepileptic Drugs. Pediatric Pharmacotherapy. A Monthly Newsletter for Health Care Professionals from the University of Virginia Children's Hospital v 18 (12) [On-line information]. PDF available for download through http://www.medicine.virginia.edu. Accessed April 2013.

Groot, M. et. al. (2012). Epilepsy in Patients With a Brain Tumour, Focal Epilepsy Requires Focused Treatment. Brain. V 135(4):1002-1016. [On-line information]. Available online at http://www.medscape.com/viewarticle/763947_1 through http://www.medscape.com. Accessed April 2013.

St. Louis E. Monitoring Antiepileptic Drugs: A Level-headed Approach. Curr Neuropharmacol. 2009 June; 7(2): 115–119. Available online at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730002/ through http://www.ncbi.nlm.nih.gov. Accessed April 2013.

Krasowski M. Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications. Pharmaceuticals (Basel). 2010 June 11; 3(6): 1909–1935. Available online at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904466/#R7 through http://www.ncbi.nlm.nih.gov. Accessed April 2013.